Phase II study of vinorelbine administer
โ
Nuhad K. Ibrahim; Zia Rahman; Vicente Valero; Jie Willey; Richard L. Theriault;
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 75 KB
๐ 2 views
## BACKGROUND. Vinorelbine given by weekly bolus injection is active and less toxic than bolus vinblastine in the treatment of patients with metastatic breast carcinoma. Vinblastine given by 5-day continuous infusion showed a steep doseresponse curve. Pharmacokinetic studies of vinorelbine showed